Objectives To compare the clinical characteristics, burden of disease (eg, disease activity,
function, quality of life), treatment modalities and treatment effect in patients with radiographic …

… DMARDs (tsDMARDs, ie, Janus kinase inhibitors) for patients who have Ankylosing
Spondylitis Disease Activity Score ≥2.1 and failed ≥2 NSAIDs and also have either elevated C …

… Author links open overlay panel Clementina López-Medina a b c , Anna Moltó a b … of the
disease, by including MRI findings and an abnormal C-reactive protein (CRP) level in a set of …

… Dr Dernis, Dr Ruyssen-Witrand, Dr Lenaerts, Dr Lopez-Medina, Dr Sparsa, Dr Starmans-Kool,
Dr C Webers, Dr Pouplin, Dr Soubrier and Dr Joos have nothing to declare. …

… limbs/large joints) and natural history (transient, continuous, intermittent or progressive); (b)
‘root-joint’ (ie, hip and shoulder) involvement in the past according to the rheumatologist, (c) …

The main symptom in patients with axial spondyloarthritis (axSpA) is inflammatory back pain,
caused principally by inflammation of the sacroiliac joints and the spine. However, not all …

To evaluate quality of life (QoL) in patients with axial spondyloarthritis (axSpA) and its association
with disease activity, functionality, structural damage, and spinal mobility, using patient-…

We read with interest the letter published by Bozzalla Cassione et al, 1 in which authors
evaluated 165 patients with systemic lupus erythematosus using telemedicine as the follow-up …

… C. López-Medina11, … , Pfizer, UCB Pharma, Grant/research support from: UCB, Novartis,
Clementina López-Medina Speakers bureau: AbbVie, Eli Lilly, Novartis, Janssen, UCB Pharma, …

Aims To explore the clinical and radiographical characteristics of axial psoriatic arthritis (PsA)
and to compare it with ankylosing spondylitis (AS) with psoriasis. Methods Cross-sectional …